Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate ...

UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a ...

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and ...

An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast ...

The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of ...

In this manuscript, Yao et al. present solid evidence to show that MnMYL3 may serve as a receptor for NNV via macropinocytosis. This manuscript is valuable for understanding the molecular mechanisms ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

Nidlegy is a fusion protein commercialized by Philogen, with a leading Phase III program in Metastatic Melanoma.

Nicoya PuraTea is a nutritional support intricately fabricated to support healthy weight loss. It uses selected ingred ...